| __timestamp | Amneal Pharmaceuticals, Inc. | Telix Pharmaceuticals Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 335989000 | 22622695 |
| Thursday, January 1, 2015 | 367054000 | 24863028 |
| Friday, January 1, 2016 | 420770000 | 21351001 |
| Sunday, January 1, 2017 | 507476000 | 53837297 |
| Monday, January 1, 2018 | 946588000 | 16080096 |
| Tuesday, January 1, 2019 | 1273376000 | 18525736 |
| Wednesday, January 1, 2020 | 1364130000 | 2024000 |
| Friday, January 1, 2021 | 1324696000 | 2548000 |
| Saturday, January 1, 2022 | 1427596000 | 61556000 |
| Sunday, January 1, 2023 | 1573042000 | 188157000 |
Infusing magic into the data realm
In the ever-evolving landscape of pharmaceuticals, understanding cost structures is pivotal. This analysis delves into the cost of revenue trends for Telix Pharmaceuticals Limited and Amneal Pharmaceuticals, Inc. over the past decade.
From 2014 to 2023, Amneal Pharmaceuticals, Inc. has seen a staggering 368% increase in its cost of revenue, peaking in 2023. This growth reflects the company's expanding operations and market reach. In contrast, Telix Pharmaceuticals Limited, while smaller in scale, has experienced a remarkable 730% surge in costs, indicating rapid growth and investment in innovation.
For investors and stakeholders, these trends highlight the strategic priorities of each company. Amneal's steady increase suggests a focus on scaling operations, while Telix's sharp rise points to aggressive R&D investments. Understanding these dynamics is crucial for making informed investment decisions in the pharmaceutical sector.
Cost of Revenue Comparison: Eli Lilly and Company vs Amneal Pharmaceuticals, Inc.
Cost Insights: Breaking Down Sanofi and Telix Pharmaceuticals Limited's Expenses
Gilead Sciences, Inc. vs Amneal Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Zoetis Inc. vs Amneal Pharmaceuticals, Inc.
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Telix Pharmaceuticals Limited
Cost of Revenue Trends: Walgreens Boots Alliance, Inc. vs Amneal Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Exelixis, Inc. and Telix Pharmaceuticals Limited
Comparing Cost of Revenue Efficiency: Cytokinetics, Incorporated vs Telix Pharmaceuticals Limited
Telix Pharmaceuticals Limited vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Cost of Revenue Comparison: Amneal Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.